organization · Reporting owner
APPLE TREE PARTNERS II LP
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Rein Therapeutics, Inc.
Report date July 06, 2018 · Filed July 10, 2018
Section 16 reporting ended · disclosed 2018-07-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-07-06 · Other · Disposed 1,380,241 · Balance 0 F1: On July 6, 2018, Apple Tree Partners II, L.P. distributed 1,380,241 shares of the Issuer's Common Stock on a pro rata basis to its partners for no consideration. Following the distribution, Apple Tree Partners II, L.P. was no longer a holder of record of the Issuer's shares. F2: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares previously held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison had sole voting and investment power over the shares previously held by Apple Tree Partners II, L.P. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 6, 2018, Apple Tree Partners II, L.P. distributed 1,380,241 shares of the Issuer's Common Stock on a pro rata basis to its partners for no consideration. Following the distribution, Apple Tree Partners II, L.P. was no longer a holder of record of the Issuer's shares.
F2: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares previously held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison had sole voting and investment power over the shares previously held by Apple Tree Partners II, L.P.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2018 Filed Jul 10, 2018 16:26 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | OtherCommon Stock | 1,380,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000906 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On July 6, 2018, Apple Tree Partners II, L.P. distributed 1,380,241 shares of the Issuer's Common Stock on a pro rata basis to its partners for no consideration. Following the distribution, Apple Tree Partners II, L.P. was no longer a holder of record of the Issuer's shares. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares previously held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison had sole voting and investment power over the shares previously held by Apple Tree Partners II, L.P. Read SEC document |
| June 26, 2018 Filed Jun 26, 2018 18:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 10,528 | $5.45 | $57,424.98 |
DisclosureSEC source: 0001012975-18-000866 · edgar.xml · nonDerivative · entry 3 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,380,241 F4 · price: The transaction was executed in multiple trades at prices ranging from $5.30 to $5.75. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 25, 2018 Filed Jun 26, 2018 18:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 913 | $5.86 | $5,353.01 |
DisclosureSEC source: 0001012975-18-000866 · edgar.xml · nonDerivative · entry 2 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390,769 F3 · price: The transaction was executed in multiple trades at prices ranging from $5.75 to $6.00. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 18:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 94,816 | $5.98 | $566,743.68 |
DisclosureSEC source: 0001012975-18-000866 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,391,682 F1 · price: The transaction was executed in multiple trades at prices ranging from $5.66 to $6.12. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 21, 2018 Filed Jun 21, 2018 21:36 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,447 | $5.30 | $7,669.10 |
DisclosureSEC source: 0001012975-18-000862 · edgar.xml · nonDerivative · entry 2 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,486,498 F1 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 21:36 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 5,200 | $5.30 | $27,563.64 |
DisclosureSEC source: 0001012975-18-000862 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,487,945 F1 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 19, 2018 Filed Jun 19, 2018 17:30 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 139 | $5.30 | $736.70 |
DisclosureSEC source: 0001012975-18-000855 · edgar.xml · nonDerivative · entry 3 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,493,145 F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 17:30 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,432 | $5.35 | $7,661.20 |
DisclosureSEC source: 0001012975-18-000855 · edgar.xml · nonDerivative · entry 2 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,493,284 F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 17:30 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 7,961 | $5.32 | $42,345.36 |
DisclosureSEC source: 0001012975-18-000855 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,494,716 F1 · price: The transaction was executed in multiple trades at prices ranging from $5.30 to $5.38. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 17:01 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 10,843 | $5.40 | $58,557.62 |
DisclosureSEC source: 0001012975-18-000846 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,502,677 F1 · price: The transaction was executed in multiple trades at prices ranging from $5.40 to $5.435. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 11, 2018 Filed Jun 11, 2018 18:51 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 18,525 | $5.41 | $100,242.48 |
DisclosureSEC source: 0001012975-18-000512 · edgar.xml · nonDerivative · entry 3 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,513,520 F4 · price: The transaction was executed in multiple trades at prices ranging from $5.38 to $5.45. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 18:51 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 9,617 | $5.40 | $51,962.57 |
DisclosureSEC source: 0001012975-18-000512 · edgar.xml · nonDerivative · entry 2 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,532,045 F3 · price: The transaction was executed in multiple trades at prices ranging from $5.40 to $5.45. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 18:51 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 20 | $5.48 | $109.50 |
DisclosureSEC source: 0001012975-18-000512 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541,662 F1 · price: The transaction was executed in multiple trades at prices ranging from $5.45 to $5.50. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| April 19, 2018 Filed Apr 19, 2018 18:20 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 104,799 | $6.29 | $659,500.11 |
DisclosureSEC source: 0001012975-18-000358 · edgar.xml · nonDerivative · entry 2 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541,682 F2 · price: The transaction was executed in multiple trades at prices ranging from $6.25 to $7.05. The price above reflects the weighted average transaction price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F1 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 18:20 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 3,105 | $7.05 | $21,890.25 |
DisclosureSEC source: 0001012975-18-000358 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,646,481 F1 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 16:49 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 150,000 | $9.80 | $1,470,435.00 |
DisclosureSEC source: 0001012975-18-000053 · edgar.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649,586 F1 · ownership.direct: Dr. Seth L. Harrison is the general partner of Apple Tree Ventures II, L.P., the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries D Preferred Stock · Derivative | 6,781,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · derivative · entry 8 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 682,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.exercise_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.expiration_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries C-2 Preferred Stock · Derivative | 4,238,607 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · derivative · entry 7 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 426,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.exercise_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.expiration_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries C-1 Preferred Stock · Derivative | 2,967,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · derivative · entry 6 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 298,583 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.exercise_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.expiration_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries B Preferred Stock · Derivative | 3,706,056 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · derivative · entry 5 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 372,955 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.exercise_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.expiration_date: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries A-1 Preferred Stock · Derivative | 615,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · derivative · entry 4 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,192 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date. F1 · derivative.exercise_date: The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date. F1 · derivative.expiration_date: The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionSeries A Preferred Stock · Derivative | 1,250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · derivative · entry 3 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,579 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date. F1 · derivative.exercise_date: The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date. F1 · derivative.expiration_date: The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionCommon Stock | 1,780,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · nonDerivative · entry 2 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,799,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:24 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | ConversionCommon Stock | 18,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-018102 · doc4.xml · nonDerivative · entry 1 APPLE TREE PARTNERS II LP · CIK 0001143789 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date. F3 · ownership.direct: Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.